{"id":"https://openalex.org/W7112789488","doi":null,"title":"Mapping the Scientific Landscape of GLP-1 and Dual GLP-1/GIP Receptor Agonists in Obesity Treatment","display_name":"Mapping the Scientific Landscape of GLP-1 and Dual GLP-1/GIP Receptor Agonists in Obesity Treatment","alternate_titles":[],"publication_year":2025,"publication_date":"2025-11-06","ids":{"openalex":"https://openalex.org/W7112789488"},"language":"en","primary_location":{"id":"pmh:oai:run.unl.pt:10362/191043","doi":null,"is_oa":true,"landing_page_url":"http://hdl.handle.net/10362/191043","pdf_url":"https://run.unl.pt/bitstreams/86367bfd-0327-40ac-be2b-8459add3cf02/download","source":{"id":"https://openalex.org/S4306402433","display_name":"Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"master thesis"},"parent_works":[],"lineage":["https://openalex.org/W7112789488"],"child_works_count":0,"type":"dissertation","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://run.unl.pt/bitstreams/86367bfd-0327-40ac-be2b-8459add3cf02/download","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Santos, Beatriz Rodrigues dos","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I83558840","display_name":"Universidade Nova de Lisboa","ror":"https://ror.org/02xankh89","country_code":"PT","type":"education","lineage":["https://openalex.org/I83558840"]}],"countries":["PT"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Santos, Beatriz Rodrigues dos","raw_affiliation_strings":["NOVA Information Management School, Universidade Nova de Lisboa"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NOVA Information Management School, Universidade Nova de Lisboa","institution_ids":["https://openalex.org/I83558840"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I83558840"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10102","display_name":"scientometrics and bibliometrics research","score":0.4950999915599823,"subfield":{"id":"https://openalex.org/subfields/3309","display_name":"Library and Information Sciences"},"field":{"id":"https://openalex.org/fields/33","display_name":"Social Sciences"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T10102","display_name":"scientometrics and bibliometrics research","score":0.4950999915599823,"subfield":{"id":"https://openalex.org/subfields/3309","display_name":"Library and Information Sciences"},"field":{"id":"https://openalex.org/fields/33","display_name":"Social Sciences"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T12539","display_name":"Pharmacology and Obesity Treatment","score":0.4359999895095825,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11649","display_name":"Pharmaceutical industry and healthcare","score":0.02419999986886978,"subfield":{"id":"https://openalex.org/subfields/2910","display_name":"Issues, ethics and legal aspects"},"field":{"id":"https://openalex.org/fields/29","display_name":"Nursing"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/glp-1-receptor-agonists","display_name":"GLP-1 receptor agonists","score":0.9980000257492065},{"id":"https://openalex.org/keywords/gip-glp-1-receptor-agonist","display_name":"GIP/GLP-1 receptor agonist","score":0.9800000190734863},{"id":"https://openalex.org/keywords/obesity-treatment","display_name":"obesity treatment","score":0.9869999885559082},{"id":"https://openalex.org/keywords/tirzepatide","display_name":"tirzepatide","score":0.984000027179718},{"id":"https://openalex.org/keywords/scientometrics","display_name":"scientometrics","score":0.6140000224113464},{"id":"https://openalex.org/keywords/sentiment-analysis","display_name":"sentiment analysis","score":0.8399999737739563},{"id":"https://openalex.org/keywords/industry-sponsored-research","display_name":"industry-sponsored research","score":0.8519999980926514},{"id":"https://openalex.org/keywords/pharmaceutical-industry-influence","display_name":"pharmaceutical industry influence","score":0.871999979019165},{"id":"https://openalex.org/keywords/publication-trends","display_name":"publication trends","score":0.7080000042915344},{"id":"https://openalex.org/keywords/eli-lilly","display_name":"Eli Lilly","score":0.7919999957084656},{"id":"https://openalex.org/keywords/novo-nordisk","display_name":"Novo Nordisk","score":0.9010000228881836},{"id":"https://openalex.org/keywords/scientific-discourse","display_name":"scientific discourse","score":0.3889999985694885}],"concepts":[{"id":"https://openalex.org/C2780980858","wikidata":"https://www.wikidata.org/wiki/Q110022","display_name":"Dual (grammatical number)","level":2,"score":0.49889999628067017},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.47040000557899475},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.38920000195503235},{"id":"https://openalex.org/C511355011","wikidata":"https://www.wikidata.org/wiki/Q12174","display_name":"Obesity","level":2,"score":0.38510000705718994},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.37700000405311584},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.33309999108314514},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.31850001215934753},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.31790000200271606},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.2980000078678131},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.2851000130176544},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.26660001277923584},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.2660999894142151},{"id":"https://openalex.org/C135285700","wikidata":"https://www.wikidata.org/wiki/Q38173","display_name":"G protein-coupled receptor","level":3,"score":0.26350000500679016},{"id":"https://openalex.org/C2779473830","wikidata":"https://www.wikidata.org/wiki/Q1540899","display_name":"MEDLINE","level":2,"score":0.258899986743927}],"mesh":[],"locations_count":1,"locations":[{"id":"pmh:oai:run.unl.pt:10362/191043","doi":null,"is_oa":true,"landing_page_url":"http://hdl.handle.net/10362/191043","pdf_url":"https://run.unl.pt/bitstreams/86367bfd-0327-40ac-be2b-8459add3cf02/download","source":{"id":"https://openalex.org/S4306402433","display_name":"Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"master thesis"}],"best_oa_location":{"id":"pmh:oai:run.unl.pt:10362/191043","doi":null,"is_oa":true,"landing_page_url":"http://hdl.handle.net/10362/191043","pdf_url":"https://run.unl.pt/bitstreams/86367bfd-0327-40ac-be2b-8459add3cf02/download","source":{"id":"https://openalex.org/S4306402433","display_name":"Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"master thesis"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.428600013256073,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7112789488.pdf","grobid_xml":"https://content.openalex.org/works/W7112789488.grobid-xml"},"referenced_works_count":45,"referenced_works":["https://openalex.org/W1534982144","https://openalex.org/W1714980748","https://openalex.org/W1975756049","https://openalex.org/W2117402345","https://openalex.org/W2121015727","https://openalex.org/W2133122377","https://openalex.org/W2136284733","https://openalex.org/W2142947341","https://openalex.org/W2149717292","https://openalex.org/W2527920149","https://openalex.org/W2546121728","https://openalex.org/W2754718739","https://openalex.org/W2755719114","https://openalex.org/W2893883775","https://openalex.org/W2904833368","https://openalex.org/W3000407671","https://openalex.org/W3045729180","https://openalex.org/W3118371520","https://openalex.org/W3137471921","https://openalex.org/W3210916260","https://openalex.org/W4200140669","https://openalex.org/W4212791440","https://openalex.org/W4224218205","https://openalex.org/W4229010617","https://openalex.org/W4281934192","https://openalex.org/W4286213365","https://openalex.org/W4365448446","https://openalex.org/W4366351986","https://openalex.org/W4383186133","https://openalex.org/W4385318987","https://openalex.org/W4388592674","https://openalex.org/W4389480516","https://openalex.org/W4389555309","https://openalex.org/W4395085097","https://openalex.org/W4396214724","https://openalex.org/W4400415068","https://openalex.org/W4402604979","https://openalex.org/W4404437149","https://openalex.org/W4405031599","https://openalex.org/W4406156729","https://openalex.org/W4406872990","https://openalex.org/W4407010133","https://openalex.org/W4409268157","https://openalex.org/W4410277932","https://openalex.org/W7133536180"],"related_works":["https://openalex.org/W6980082061","https://openalex.org/W7131864859","https://openalex.org/W7120376236","https://openalex.org/W7024360855","https://openalex.org/W7037897428","https://openalex.org/W7145584333","https://openalex.org/W7146998114","https://openalex.org/W1958024424","https://openalex.org/W4402621680","https://openalex.org/W4388853049"],"abstract_inverted_index":{"This":[0],"thesis":[1],"investigates":[2],"the":[3,31,48,97,106,112,125,148,157,169],"evolution":[4],"of":[5,50,114,128,150],"scientific":[6,129,186],"literature":[7,73],"on":[8,59],"GLP-1":[9],"and":[10,20,27,36,44,47,88,109,119,138,156,174,185],"dual":[11,126],"GLP-1/GIP":[12],"receptor":[13],"agonists":[14],"for":[15,69,135,142,161],"obesity":[16],"treatment":[17],"between":[18],"2010":[19],"2024.":[21],"Using":[22],"data":[23,176],"retrieved":[24],"from":[25],"OpenAlex":[26],"processed":[28],"in":[29,77],"R,":[30],"study":[32],"applies":[33],"scientometric":[34],"techniques":[35],"sentiment":[37,55],"analysis":[38,56,170],"to":[39,92,96,153,180],"assess":[40,181],"publication":[41,85],"trends,":[42],"institutional":[43],"geographic":[45],"contributions,":[46],"influence":[49,113],"industry-affiliated":[51],"research.":[52],"A":[53],"comparative":[54],"was":[57,74],"performed":[58],"industry":[60],"versus":[61],"non-industry":[62],"publications,":[63],"revealing":[64],"notable":[65],"tonal":[66],"discrepancies,":[67],"particularly":[68,179],"Tirzepatide,":[70],"where":[71],"early":[72],"more":[75,172],"positive":[76],"industry-sponsored":[78],"studies.":[79],"Additionally,":[80],"author-level":[81],"metrics":[82],"such":[83],"as":[84,131,171],"counts,":[86],"citations,":[87],"h-indexes":[89],"were":[90],"used":[91],"evaluate":[93],"individual":[94],"contributions":[95],"field.":[98],"Results":[99],"highlight":[100],"a":[101,133,139],"research":[102,166],"landscape":[103],"dominated":[104],"by":[105],"United":[107],"States":[108],"Denmark,":[110],"reflecting":[111],"pharmaceutical":[115],"leaders":[116],"Eli":[117],"Lilly":[118],"Novo":[120],"Nordisk.":[121],"The":[122],"findings":[123],"underscore":[124],"role":[127],"publishing":[130],"both":[132],"vehicle":[134],"evidence":[136],"generation":[137],"strategic":[140],"tool":[141],"shaping":[143],"drug":[144],"narratives.":[145],"Limitations":[146],"include":[147],"exclusion":[149],"studies":[151],"due":[152],"missing":[154],"metadata":[155],"short":[158],"observation":[159],"window":[160],"newly":[162],"approved":[163],"therapies.":[164],"Future":[165],"should":[167],"update":[168],"longitudinal":[173],"real-world":[175],"become":[177],"available,":[178],"long-term":[182],"safety,":[183],"efficacy,":[184],"discourse":[187],"evolution.":[188]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W7112789488","counts_by_year":[],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2025-12-10T00:00:00"}
